Active, Not Recruiting
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06914687
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +11 more
- Locations
-
- Fudan University Shanghai Cancer Hospital Shanghai, Shanghai Municipality, China